BHST
BioHarvest Sciences Inc. Common Stock (NASDAQ)
Consumer Defensive — Packaged Foods
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Price History
Fundamentals
| Market Cap | $65.96M |
| P/E Ratio (TTM) | - |
| Forward P/E | -17.64 |
| EPS (TTM) | $-0.58 |
| Dividend Yield | - |
| Profit Margin | -32.54% |
| Revenue Growth | 8.20% |
| ROE | -103.29% |
| Debt/Equity | 60.98 |
| Recommendation | None |
| Analyst Target | $12.75 |
| Analysts | 4 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 42.4 |
| Beta | 1.35 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $12.80 |
| 52-Week Low | $2.75 |
| 50-Day Avg | $3.67 |
| 200-Day Avg | $5.78 |
| Avg Volume | 33.5K |
| Volume | 94.3K |
Performance Analysis
NEUTRALBHST presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 12:59 UTC
Back to Screener Export Report